Abstract
Two patients experienced hepatotoxicity associated with erythromycin estolate (ilosone®) usage, followed 13 and 15 years later by an hepatotoxic reaction with administration of erythromycin ethylsuccinate (E.E.S.®). These cases provide further evidence for erythromycin ethylsuccinate-associated hepatotoxicity and demonstrate erythromycin crosssensitivity after previous erythromycin estolate liver injury. Hepatotoxicity to both estolate and ethylsuccinate preparations of erythromycin stimulates speculation regarding the potentially hepatotoxic moiety of the erythromycin molecule. Furthermore, these cases suggest that all erythromycin preparations should be avoided or used only with careful monitoring in patients with previous erythromycin-associated liver injury.
Similar content being viewed by others
References
Cacace LG, Schweigert BF, Gildon AM: Erythromycin estolate induced hepatotoxicity: Report of a case and review of the literature. Drug Intell Clin Pharm 11:22–25, 1977
Zafrani ES, Ishak KG, Rudzki C: Cholestatic and hepatocellular injury associated with erythromycin esters. Report of nine cases. Dig Dis Sci 24:385–396, 1979
Zimmerman HJ: Hepatotoxicity. New York, Appleton-Century-Crofts, 1978
Anonymous. Choice and uses of the erythromycin drugs. Med Lett Drugs Ther 12:35–36, 1970
Ticktin HE, Robinson MM: Effects of some antimicrobial agents on the liver. Ann NY Acad Sci 104:1080–1092, 1963
Tolman KG, Sannella JJ, Freston JW: Chemical structure of erythromycin and hepatotoxicity. Ann Intern Med 81:58–60, 1974
Pessayre D, Marie C, Benhamou JP: Hepatite due au priopionate d'erythromycine. Arch Fr Mal App Dig 65:405–408, 1976
Klatskin G: Toxic and drug-induced hepatitis.In Diseases of the Liver, 4th ed. L Schiff (ed). Philadelphia, JB Lippincott, 1975, pp 604–710
Viteri AL, Greene JF Jr, Dyck WP: Erythromycin ethylsuccinate-induced cholestasis. Gastroenterology 76:1007–1008, 1979
Sullivan D, Csuka ME, Blanchard B: Erythromycin ethylsuccinate hepatotoxicity. J Am Med Assoc 243:1074, 1980
Gilbert FI Jr: Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. J Am Med Assoc 182: 1048–1050, 1962
Farmer CD, Hoffman HN II, Shorter RG, Thurber DL, Bartholomew LG: Intrahepatic cholestasis associated with the ingestion of erythromycin estolate (Ilosone). Gastroenterology. 45:157–160, 1963
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keeffe, E.B., Reis, T.C. & Berland, J.E. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Digest Dis Sci 27, 701–704 (1982). https://doi.org/10.1007/BF01393764
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01393764